Value of tissue elastography in the prediction of efficacy of neoadjuvant chemotherapy in breast cancer

被引:5
|
作者
Fang, Chao [1 ]
Wu, Tingting [1 ]
Zhou, Yingying [1 ]
Xue, Jun [1 ]
Yang, Weiwei [1 ]
机构
[1] Zhabei Cent Hosp, 619 Zhonghua Xin Rd, Shanghai 200043, Peoples R China
来源
JOURNAL OF BUON | 2019年 / 24卷 / 02期
关键词
breast cancer; neoadjuvant chemotherapy; real-time tissue elastography; strain ratio; ULTRASOUND ELASTOGRAPHY; PATHOLOGICAL RESPONSE; SHEAR-WAVE; SYSTEM;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of the present study was to explore the value of real-time tissue elastography (RTE) in predicting the efficacy of neoadjuvant chemotherapy (NAC) in breast cancer. Methods: A total of 60 patients with breast cancer who received NAC in our hospital were evaluated. According to the pathological results, 47 patients were included in the significant response group and 13 patients in the non-significant response group. The maximum diameter and strain ratio (B/A ratio) of lesions before and 1st, 2nd, 4th and 6th week after NAC were recorded and compared. The receiver operation characteristics (ROC) curve of the lesion diameter and strain rate ratio (B/A value) were used to predict the value of NAC efficacy. Results: The lesions in the two groups showed a honeycomb-like reduction after NAC. The blue color in the elastic image gradually decreased, and the green color gradually increased. Repeated analyses of variance (ANOVA) found that the maximum diameter and B/A value showed a downward trend within 6 weeks of NAC treatment. The maximum diameter and B/A value in the significant response group were significantly lower than the non-significant response group before and after the NAC. There was an interaction in the maximum diameter and B/A value between the significant response group and the non-significant response group. The above differences were statistically significant (all p <0.05). The area under the curve (AUC) of Delta B/A value at 2nd week of NAC was maximal (0.944), and the best diagnostic point was 5.64. The sensitivity was 92.31% and the specificity 87.23%. Conclusions: Delta B/A value at 2nd week of NAC is helpful in predicting the therapeutic effect of NAC in breast cancer.
引用
收藏
页码:555 / 559
页数:5
相关论文
共 50 条
  • [41] Prognostic Value of Genomic Analysis after Neoadjuvant Chemotherapy for Breast Cancer
    Mayer, E. L.
    Shak, S.
    Miller, K.
    Rugo, H.
    Carey, L.
    Ryabin, N.
    Pomeroy, C.
    Yoshizawa, C.
    Winer, E. P.
    Burstein, H. J.
    CANCER RESEARCH, 2010, 70
  • [42] Potential application value of Doppler ultrasonography in neoadjuvant chemotherapy for breast cancer
    Santos, Donizeti Willian
    Fernandes Junior, Paulo Cesar
    Guedes Junior, Cairo Antonio
    Debs Diniz, Angelica Lemos
    MINERVA GINECOLOGICA, 2016, 68 (04): : 405 - 411
  • [43] Efficacy of neoadjuvant chemotherapy and Annexin A3 expression in breast cancer
    Zhu, Shiguang
    Li, Yalun
    Wang, Yidan
    Cao, Jianqiao
    Li, Xiaohui
    Wang, Ji
    Wang, Xingmiao
    JOURNAL OF BUON, 2019, 24 (02): : 522 - 528
  • [44] Neoadjuvant chemotherapy for breast cancer: an evaluation of its efficacy and research progress
    Chen, Yushi
    Qi, Yu
    Wang, Kuansong
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [45] Efficacy and prognosis of neoadjuvant chemotherapy is correlated with breast cancer molecular classification
    Dai, Xiao-li
    Han, Zhong-bao
    Yang, You-tian
    Qiu, Jing
    Liu, Yi-fei
    Feng, Yi-zhong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (07) : 517 - 522
  • [46] MR Imaging for the Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy Response
    Hylton, Nola
    RADIOLOGY, 2013, 266 (01) : 367 - 367
  • [47] Multimodal Prediction of Breast Cancer Relapse Prior to Neoadjuvant Chemotherapy Treatment
    Rabinovici-Cohen, Simona
    Abutbul, Ami
    Fernandez, Xose M.
    Cubelos, Oliver Hijano
    Perek, Shaked
    Tlusty, Tal
    PREDICTIVE INTELLIGENCE IN MEDICINE, PRIME 2020, 2020, 12329 : 188 - 199
  • [48] Prediction of pathological response to neoadjuvant chemotherapy in breast cancer patients by imaging
    Kaise, Hiroshi
    Shimizu, Fumika
    Akazawa, Kohei
    Hasegawa, Yoshie
    Horiguchi, Jun
    Miura, Daishu
    Kohno, Norio
    Ishikawa, Takashi
    JOURNAL OF SURGICAL RESEARCH, 2018, 225 : 175 - 180
  • [49] Neoadjuvant chemotherapy in breast cancer - prediction of pathological response by FDG PET
    Quercia, S.
    Zamagni, C.
    Bernardi, A.
    Fanti, S.
    Santini, D.
    Massari, F.
    Rosati, M.
    Cacciari, N.
    Taffurelli, M.
    Martoni, A. A.
    EJC SUPPLEMENTS, 2008, 6 (07): : 62 - 62
  • [50] Clinical implications of serum miR-34a in breast cancer and its predictive value for the efficacy of neoadjuvant chemotherapy
    Hong, Yanyan
    Chen, Tingting
    He, Qian
    Ma, Qiang
    Chen, Zhendong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (06): : 2711 - 2718